Catheter Precision Inc. (AMEX:VTAK) shares traded 106.49% higher at $0.91 on Wall Street last session.
VTAK stock price is now 11.33% away from the 50-day moving average and -75.02% away from the 200-day moving average. The market capitalization of the company currently stands at $2.55M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $9 to $1.50, Piper Jaffray Downgraded its rating from Overweight to Neutral for Catheter Precision Inc. (AMEX: VTAK). On November 02, 2018, Maxim Group recently initiated its ‘Buy’ rating on the stock quoting a target price of $23
In other news, JENKINS DAVID A, Executive Chairman and CEO bought 9,528 shares of the company’s stock on Jan 23 ’24. The stock was bought for $5,694 at an average price of $0.60. Upon completion of the transaction, the Executive Chairman and CEO now directly owns 329,856 shares in the company, valued at $0.3 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 22 ’24, Executive Chairman and CEO JENKINS DAVID A bought 9,528 shares of the business’s stock. A total of $4,092 was incurred on buying the stock at an average price of $0.43. This leaves the insider owning 320,328 shares of the company worth $0.29 million. A total of 14.18% of the company’s stock is owned by insiders.
During the past 12 months, Catheter Precision Inc. has had a low of $0.31 and a high of $8.40. As of last week, the company has a debt-to-equity ratio of 0.66, a current ratio of 0.12, and a quick ratio of 0.10. The fifty day moving average price for VTAK is $0.8176 and a two-hundred day moving average price translates $3.6445 for the stock.
The latest earnings results from Catheter Precision Inc. (AMEX: VTAK) was released for 2024-06-30. The net profit margin was -2176.83% and return on equity was -49.81% for VTAK. The company reported revenue of $93000.0 for the quarter, compared to $96000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -3.12 percent. For the current quarter, analysts expect VTAK to generate $1.06M in revenue.
